Back

Letter to the editor concerning: Catastrophic apical ballooning in obstructive hypertrophic cardiomyopathy patient treated with mavacamten

European Heart Journal - Case Reports

1 November 2025
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
The evolution of the obstructive HCM therapeutic landscape: emerging evidence about cardiac myosin inhibitors
31 August 2025
thumbnail
Congress Session
Cardiomyopathies cases
11 December 2025
thumbnail
Congress Presentation
Effects of mavacamten on left atrial function in hypertrophic obstructive cardiomyopathy
13 December 2024
thumbnail
Webinar
The spectrum of management options for the left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
28 October 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources